Writer profile
Emily Watson
Health Education Editor · writes on ADHD Treatment & Wellness
Emily Watson edits our treatment and wellness coverage. She has a health-writing and editing background and focuses on the questions that come up around therapy and medication without ever giving personal prescriptive advice.
Her writing explains how a clinician chooses between stimulants and non-stimulants, what the common side effects actually look like, how CBT for ADHD differs from generic CBT, and where popular online advice gets the evidence wrong. She is particularly attentive to claims that 'X herb' or 'Y supplement' treats ADHD and will flag them against published reviews.
Emily does not recommend specific drugs, dosages, or brands. When a reader question needs a dosage answer, the article sends them to a licensed prescriber.
What this writer covers
- ADHD medications (stimulants and non-stimulants), at an educational level
- Therapy approaches (CBT, DBT-informed skills, ADHD-specific coaching)
- Side effects, adherence, and what to bring up with a prescriber
- Lifestyle interventions with real evidence behind them
How they research a piece
Emily cross-checks every treatment claim against the original clinical guideline (NICE NG87, CDC, NIMH) before it ships. Where the evidence base is still weak — most supplements, most neurofeedback — the article says so directly.
What they are not
Emily is a health education editor. She is not a physician, pharmacist, psychologist, or therapist. None of her articles should be used in place of a conversation with a licensed prescriber.
We keep writer credentials honest on purpose. If you want the full methodology — source tiers, correction policy, how we handle medical claims — read our editorial & sourcing policy.
Articles by Emily Watson
April 12, 2026
ADHD in Children: Signs, Diagnosis & Support
Childhood ADHD shows up as persistent inattention, hyperactivity, or impulsivity beyond typical behaviour. See the signs by age, how diagnosis works, and real support options.
April 4, 2026
Untreated ADHD in Adults: Risks and Long-Term Effects
A 351-study review found untreated ADHD worsens outcomes in every major life domain. Learn the mood, work, and health risks, and what changes with care.
April 2, 2026
New ADHD Medications Coming in 2026: Pipeline Updates
Non-stimulants, glutamate modulators, and repurposed drugs are in trials for ADHD in 2026. Here is the realistic pipeline, timelines, and what it means.
April 1, 2026
ADHD in Teens: Challenges, Identity & Diagnosis
Adolescence reshapes ADHD as hyperactivity fades and executive-function demand rises. Here is how to spot the shifts, support your teen, and plan next steps.
March 24, 2026
ADHD and Physical Health: Obesity, Diabetes, Heart Disease & More
High childhood ADHD traits predict more physical multimorbidity by age 46. See the obesity, heart, diabetes, and asthma links and what to screen for.
March 21, 2026
Probiotics for ADHD: Can Gut Bacteria Improve Focus?
Seven randomised trials, 379 people, no significant effect on core ADHD symptoms. Here is where probiotics might still help — and where they do not.
March 19, 2026
ADHD Supplements: What the Evidence Actually Says
Omega-3s, vitamin D, zinc, magnesium, Bacopa: what Cochrane reviews and recent trials say about ADHD supplements, and which marketing claims to ignore.
March 15, 2026
ADHD and Diet: Foods That May Help or Hurt
A 2019 meta-analysis tied healthy diets to fewer ADHD symptoms. See what the Mediterranean pattern, omega-3s, sugar, and dyes really do to focus.
March 8, 2026
ADHD in School: Classroom Challenges & Support Strategies
Working memory, time blindness, and lost worksheets shape every school day. Here is what works — from 504 vs IEP to testing accommodations and homework.
March 2, 2026
Paracetamol in Pregnancy and ADHD: The Myth Debunked
A Swedish sibling study of 2.4 million children found no causal link between paracetamol in pregnancy and ADHD. Here is what the newer evidence means.
March 1, 2026
Can You Take ADHD Medication During Pregnancy?
Stimulants, atomoxetine, modafinil: what 2020-2026 cohort studies and reviews say about ADHD medication in pregnancy, plus how to plan with your care team.
February 24, 2026
ADHD and Alcohol: Effects, Risks & Guidance
Up to 43% of adults with ADHD develop an alcohol use disorder (Luderer, 2021). Why self-medication happens, plus medication interactions and harm reduction.
February 22, 2026
ADHD and Nicotine: Why Smoking Is More Common
Adults with ADHD smoke at two to three times the general rate. Learn why nicotine appeals to the ADHD brain and how to quit with ADHD-specific support.
February 18, 2026
ADHD and Your Body Clock: The Circadian Rhythm Connection
Dim-light melatonin onset is delayed by about 90 minutes in adults with ADHD (Luu, 2025). How light timing, melatonin, and fixed wake times can help pull it back.
February 15, 2026
ADHD and Sleep: Why It's Hard and What Actually Helps
Up to 80% of adults with ADHD have sleep problems driven by delayed circadian rhythms and mental arousal. Evidence-based fixes, medication timing, more.
January 11, 2026
Non-Medication ADHD Treatments: Therapy, Lifestyle & Evidence
CBT has the strongest evidence among non-medication ADHD treatments for adults. Exercise, mindfulness, and coaching also show promise, with important caveats.
January 10, 2026
Non-Stimulant ADHD Medications: Options and What to Expect
Four non-stimulant ADHD medications, atomoxetine, viloxazine, guanfacine, clonidine. Compare how each works, who benefits, and likely side effects.
January 9, 2026
Stimulants vs Non-Stimulants for ADHD: How to Decide
Stimulants usually kick in within an hour; non-stimulants need weeks. How clinicians choose between the two classes, and what to ask at the appointment.
January 8, 2026
ADHD Medication Side Effects: What to Expect and When to Act
About half of adults on ADHD medication report a side effect. Learn which effects are common, which need monitoring, and when to call your prescriber.
January 5, 2026
ADHD Medications: Types, How They Work & What to Expect
Dopamine, norepinephrine, and two drug classes: how stimulant and non-stimulant ADHD medications actually work, plus what titration looks like.
January 1, 2026
The Dark Side of ADHD: Real Risks and Challenges
14% vs 2.7% suicide attempts, prison overrepresentation, accidents, and debt — the real risks of untreated ADHD, and how treatment changes the trajectory.
Why we publish writer profiles. Our articles are written by health writers and editors, not practising clinicians. We want that to be obvious — both because it is accurate, and because it affects how you should weight what we write. For medical decisions, please consult a licensed clinician in your jurisdiction.